The COVID-19 pandemic is causing a major burden on personal health, healthcare
systems and the global economy. For the last two years the COVID-19 pandemic has
dramatically changed our lives in many personal and professional areas. For millions
of us, due to infection rates, but also to protection measures such as lockdowns the
corona pandemic has significantly changed the way we work, how we live, and how we
interact with technology. In addition to the development of effective vaccines,
anti-viral and anti-inflammation strategies are of eminent importance to treat
people with acute infection or at least prevent serious negative outcomes. In
contrast to the fast development of several effective vaccines that were remarkably
available already after one year of the pandemic, novel effective anti-viral
compounds are still in development. The only currently used effective medications
against severe SARS-CoV-2 virus infection are corticosteroids [1].
